Literature DB >> 18585452

The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.

Corinna Weber-Schoendorfer1, Doreen Hannemann, Reinhard Meister, Elisabeth Eléfant, Benedikte Cuppers-Maarschalkerweerd, Judy Arnon, Thierry Vial, Elvira Rodriguez-Pinilla, Maurizio Clementi, Elisabeth Robert-Gnansia, Marco De Santis, Heli Malm, Alla Dolivo, Christof Schaefer.   

Abstract

OBJECTIVE: To assess the safety of calcium channel blockers during the first trimester of pregnancy. STUDY
DESIGN: A multicenter (n=11), prospective observational study of the European Network of Teratology Information Services (ENTIS). The rate of major birth defects was compared between a cohort of pregnant women exposed to calcium channel blockers during the first trimester (n=299) and a control group not exposed to potential teratogens (n=806).
RESULTS: Major birth defects were not more common in the study group than in the control group. Birth weight was significantly lower in exposed term newborns. There were more preterm infants in the study group than in the control group (23.8% vs. 6.5%). These adverse effects are more likely due to the underlying disease than to the medication.
CONCLUSION: This study suggests that calcium channel blockers during the first trimester of pregnancy do not represent a major teratogenic risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585452     DOI: 10.1016/j.reprotox.2008.05.065

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  15 in total

1.  Cardiοvascular diseases in pregnancy.

Authors:  Dimitrios Godosis; Spyridon Komaitis; Konstantinos Tziomalos; Maria Baltatzi; Georgios Ntaios; Christos G Savopoulos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

Review 2.  Maternal cardiac arrhythmias during pregnancy and lactation.

Authors:  Rachael Cordina; Mark A McGuire
Journal:  Obstet Med       Date:  2010-03-04

3.  Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE).

Authors:  Demosthenes G Katritsis; Giuseppe Boriani; Francisco G Cosio; Pierre Jais; Gerhard Hindricks; Mark E Josephson; Roberto Keegan; Bradley P Knight; Karl-Heinz Kuck; Deirdre A Lane; Gregory Yh Lip; Helena Malmborg; Hakan Oral; Carlo Pappone; Sakis Themistoclakis; Kathryn A Wood; Kim Young-Hoon; Carina Blomström Lundqvist
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

Review 4.  Kidney stones during pregnancy.

Authors:  Michelle J Semins; Brian R Matlaga
Journal:  Nat Rev Urol       Date:  2014-02-11       Impact factor: 14.432

Review 5.  Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis.

Authors:  Anushuya Ramakrishnan; Laura J Lee; Laura E Mitchell; A J Agopian
Journal:  Pediatr Cardiol       Date:  2015-05-08       Impact factor: 1.655

Review 6.  Use of medication for cardiovascular disease during pregnancy.

Authors:  Petronella G Pieper
Journal:  Nat Rev Cardiol       Date:  2015-12       Impact factor: 32.419

Review 7.  In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review.

Authors:  Catherine A Fitton; Markus F C Steiner; Lorna Aucott; Jill P Pell; Daniel F Mackay; Michael Fleming; James S McLay
Journal:  J Hypertens       Date:  2017-11       Impact factor: 4.844

Review 8.  Management of urolithiasis in pregnancy.

Authors:  Michelle Jo Semins; Brian R Matlaga
Journal:  Int J Womens Health       Date:  2013-09-30

Review 9.  Management of Type 1 Diabetes in Pregnancy.

Authors:  Anna Z Feldman; Florence M Brown
Journal:  Curr Diab Rep       Date:  2016-08       Impact factor: 4.810

Review 10.  Glomerular Disease in Women.

Authors:  Kate Wiles; Liz Lightstone
Journal:  Kidney Int Rep       Date:  2018-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.